Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jalinous Pharmaceutical Company is a prominent Iranian pharmaceutical manufacturer headquartered in Tehran, established in 1977. The company specializes in the production of a wide range of generic finished dosage forms, including tablets, capsules, and oral liquids. Its extensive portfolio covers diverse therapeutic areas such as cardiovascular health, central nervous system disorders, and gastrointestinal treatments. Jalinous operates modern manufacturing facilities that comply with international Good Manufacturing Practice (GMP) standards to supply the domestic Iranian market and regional exports. The company is recognized for its commitment to quality and its significant role in providing affordable essential medicines within the Middle Eastern healthcare landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jalinous Pharmaceutical.